Analysen von Richard Vosser
| 16.07.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 09.07.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 09.07.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 09.07.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.07.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 07.07.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 01.07.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.07.20 | Roche overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 29.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 25.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 25.06.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 25.06.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 19.06.20 | Roche overweight | JP Morgan Chase & Co. | |
| 19.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.06.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.06.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.06.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 29.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.05.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 28.05.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 27.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 26.05.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 22.05.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 15.05.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 14.05.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 04.05.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | Merck Neutral | JP Morgan Chase & Co. | |
| 29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.20 | Bayer Neutral | JP Morgan Chase & Co. | |
| 27.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 21.04.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |